Description

Injectable Drug Delivery is an industry focused on two overarching topics the development of the device and the interaction between drug product and device. SAE’s 2024 Injectable Drug Delivery conference brings together a complete big pharma speaker line-up providing technical updates on the relationship between drug product formulation and the device primary packaging, with considerations for formulation strategies, extractables and leachables and toxicological testing of injectable devices.

This conference brings case studies from senior big pharma representatives providing an opportunity to discuss formulation considerations in depth for parenteral packaging, this is the perfect opportunity to benchmark your drug delivery programme and optimise the development of your injectable portfolio.

The 2024 conference differentiates itself to other injectables conferences through focused technical presentations on device primary packaging and material selection for the advanced drug products of the future with case studies from Sanofi, Roche and Bayer. Additionally, focused presentations on user driven platform development and the role this has had at AstraZeneca and Novo Nordisk to enhance their parenteral delivery portfolio.
These technical sessions bring together leading scientists working directly in the field to allow for an intimate and direct networking opportunity. This focus on technical, in-depth presentations allows for a tailored audience of device developers compared to wide and varied audience of competitors conferences.

What will you gain?

– Evaluate how devices can be co-developed alongside drug products to foster a collaborative approach to improve biocompatibility and effective toxicological testing

– Expand on design strategies for injectable delivery of advanced modalities, including cell and gene therapies, large molecule delivery and sub-zero device requirements

– Learn through focused presentations tailored to a technical device development and primary packaging audience, exploring vial material and primary component selection, silicone layer thickness studies and standardisation of primary container formats

– Benefit from spotlight sessions focusing on sustainable device materials, offering comprehensive perspectives on material development and selection through to disposal

– Learn how major device developers are streamlining product development and CMC practices for effective compliance throughout and post-NDA/MAA approval

 

 

URL:
Brochure: https://go.evvnt.com/2229397-2?pid=1000